Ed Biotech said on an interactive platform on December 14 that the company has set up localization teams in key markets such as Singapore, Japan, Europe, Latin America and the “Belt and Road”, forming a global layout with the East Asian and European markets as strategic fulcrums and gradually radiating to emerging markets such as Southeast Asia, the Middle East, Africa, and Latin America. Ed's North American Laboratories mainly undertakes BD business for pharmaceutical companies. Regarding the specific share target for overseas business in the future, please stay tuned for the company's subsequent related announcements.

Ed Biotech said on an interactive platform on December 14 that the company has set up localization teams in key markets such as Singapore, Japan, Europe, Latin America and the “Belt and Road”, forming a global layout with the East Asian and European markets as strategic fulcrums and gradually radiating to emerging markets such as Southeast Asia, the Middle East, Africa, and Latin America. Ed's North American Laboratories mainly undertakes BD business for pharmaceutical companies. Regarding the specific share target for overseas business in the future, please stay tuned for the company's subsequent related announcements.